Western Europe Australia Eastern Europe Middle East Central America Africa South America Asia North America
Product Description
TRANTAS-500
Trantas - Trantas (commonly marketed as Transcam in Asia) is often prescribed for excessive bleeding. It is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin. Fibrin is the basic framework for the formation of a blood clot in hemostasis. It has roughly 8 times the antifibrinolytic activity of an older analogue, -aminocaproic acid.